参考文献/References:
[1] 夏晓天, 张永学. 影像学检查在乳腺癌的诊断及疗效评估中的应用价值[J]. 国际放射医学核医学杂志, 2010, 34(4):242-246.
[2] Kolesnikov-Gauthier H, Vanlemmens L, Baranzelli MC, et al. Predictive value of neoadjuvant chemotherapy failure in breast cancer using FDG-PET after the first course[J]. Breast Cancer Res Treat, 2012, 131(2):517-525.
[3] 董佳佳, 章斌. 多种影像学方法评价乳腺癌新辅助化疗疗效的价值比较[J]. 国际放射医学核医学杂志, 2014, 38(6):427-432.
[4] Sun Y, Wei W, Yang HW, et al. Clinical usefulness of breast-specific gamma imaging as an adjunct modality to mammography for diagnosis of breast cancer:a systemic review and meta-analysis[J]. Eur J Nucl Med Mol Imaging, 2013, 40(3):450-463.
[5] 谭辉, 张一秋, 石洪成. 核医学乳腺专用显像仪在乳腺癌诊疗中的应用[J]. 中华核医学与分子影像杂志, 2014, 34(1):73-75.
[6] 孙达, 陈伟君. 乳腺专用伽玛显像(BSGI)技术的最新进展[J]. 中国医疗器械杂志, 2015, 39(2):108-112.
[7] Sergieva SB, Timcheva KV, Hadjiolov ND. 99mTc-MIBI scintigraphy as a functional method for the evaluation of multidrug resistance in breast cancer patients[J]. J BUON, 2006, 11(1):61-68.
[8] Mankoff DA, Dunnwald LK, Gralow JR, et al. Monitoring the response of patients with locally advanced breast carcinoma to neoadjuvant chemotherapy using[Technetium 99m]-sestamibi scintimammography[J]. Cancer, 1999, 85(11):2410-2423.
[9] Spanu A, Farris A, Chessa F, et al. Planar scintimammography and SPECT in neoadjuvant chemo or hormonotherapy response evaluation in locally advanced primary breast cancer[J]. Int J Oncol, 2008, 32(6):1275-1283.
[10] Fuster D, Mu?oz M, Pavia J, et al. Quantified 99mTc-MIBI scintigraphy for predicting chemotherapy response in breast cancer patients:factors that influence the level of 99mTc-MIBI uptake[J]. Nucl Med Commun, 2002, 23(1):31-38.
[11] Novikov SN, Kanaev SV, Petr KV, et al. Technetium-99m methoxyisobutylisonitrile scintimammography for monitoring and early prediction of breast cancer response to neoadjuvant chemotherapy[J]. Nucl Med Commun, 2015, 36(8):795-801.
[12] Listewnik MH, Birkenfeld B, Foszczyńska-K?oda M, et al. Response of malignant breast tumours to neoadjuvant chemotherapy evaluated with Tc-99m MIBI[J]. Ann Acad Med Stetin, 2011, 57(1):73-78.
[13] 贾莉, 邹天宁, 夏正武, 等. 99mTc-MIBI乳腺显像评价乳腺癌新辅助化疗效果的临床价值[J]. 现代医学, 2014, 42(1):4-8.
[14] Tiling R, Linke R, Untch M, et al. 18F-FDG PET and 99mTc-sestamibi scintimammography for monitoring breast cancer response to neoadjuvant chemotherapy:a comparative study[J]. Eur J Nucl Med, 2001, 28(6):711-720.
[15] Si H, Li X. Abundant blood supply and low P-glycoprotein expression on dynamic 99mTc-MIBI imaging predicted better chemotherapy sensitivity for a breast cancer patient:a case report[J]. J Nucl Med Technol, 2012, 40(2):89-91.
[16] Dizdarevic S, Peters AM. Imaging of multidrug resistance in cancer[J]. Cancer Imaging, 2011, 11(11):1-8.
[17] Mubashar M, Harrington KJ, Chaudhary KS, et al. 99mTc-sestamibi imaging in the assessment of toremifene as a modulator of multidrug resistance in patients with breast cancer[J]. J Nucl Med, 2002, 43(4):519-525.
[18] 贾莉, 邹天宁, 夏正武, 等. 99mTc-MIBI显像预测乳腺癌新辅助化疗疗效的临床应用[J]. 临床医学, 2013, 33(11):18-20.
[19] 刘文峰, 墙华, 杨晓君, 等. 99m锝-甲氧基异丁基异腈显影预测乳腺癌新辅助化疗疗效的应用研究[J]. 宁夏医学杂志, 2010, 32(8):693-694.
[20] 张雪梅, 刘志军, 杨秀蓉. 99mTc-MIBI显像可预测乳腺癌新辅助化疗的反应性[J]. 生物医学工程与临床, 2006, 10(5):290-292, 335.
[21] 刘真真, 卢振铎, 张恒伟, 等. 99Tcm-甲氧基异丁基异腈显像对可手术乳腺癌新辅助化疗疗效的预测价值[J]. 中华肿瘤杂志, 2011, 33(7):544-546.
[22] 袁超, 李卫鹏. 99Tcm-tetrofosmin:一种评价体内P-糖蛋白功能变化的显像剂[J]. 国际放射医学核医学杂志, 2009, 33(3):144-148.
[23] Del Vecchio S, Ciarmiello A, Pace L, et al. Fractional retention of technetium-99m-sestamibi as an index of P-glycoprotein expression in untreated breast cancer patients[J]. J Nucl Med, 1997, 38(9):1348-1351.
[24] Cayre A, Cachin F, Maublant J, et al. Single static view 99mTc-sestamibi scintimammography predicts response to neoadjuvant chemotherapy and is related to MDR expression[J]. Int J Oncol, 2002, 20(5):1049-1055.
[25] 杨晓君, 王惠, 余建军. 乳腺癌99m锝-甲氧基异丁基异腈显像与三种多药耐药蛋白表达的关系[J]. 宁夏医学杂志, 2009, 31(8):681-683.
[26] 崔树德, 刘真真, 刘慧, 等. 甲氧基乙丁基异腈亲肿瘤显像与乳腺癌多药耐药类蛋白关系的研究[J]. 中华肿瘤杂志, 2005, 27(10):606-608.
[27] 林开文, 刘保平, 程兵. 乳腺癌99Tcm-MIBI显像与P-gp、MRP表达的关系[J]. 中华核医学杂志, 2005, 25(5):40-42, 75.
[28] Kao CH, Tsai SC, Liu TJ, et al. P-Glycoprotein and multidrug resistance-related protein expressions in relation to technetium-99m methoxyisobutylisonitrile scintimammography findings[J]. Cancer Res, 2001, 61(4):1412-1414.
[29] Takamura Y, Miyoshi Y, Taguchi T, et al. Prediction of chemotherapeutic response by Technetium 99m-MIBI scintigraphy in breast carcinoma patients[J]. Cancer, 2001, 92(2):232-239.
[30] Kostakoglu L, Ruacan S, Ergün EL, et al. Influence of the heterogeneity of P-glycoprotein expression on technetium-99m-MIBI uptake in breast cancer[J]. J Nucl Med, 1998, 39(6):1021-1026.
相似文献/References:
[1]马乐,张万春,李晓敏.乳腺癌前哨淋巴结核素显像新进展[J].国际放射医学核医学杂志,2016,40(2):145.[doi:10.3760/cma.j.issn.1673-4114.2016.02.012]
Ma Le,Zhang Wanchun,Li Xiaomin.Evolution of radionuclide imaging of sentinel node lymphscintigraphy in breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):145.[doi:10.3760/cma.j.issn.1673-4114.2016.02.012]
[2]樊孝廉,舒毅,曾春平,等.99Tcm-MIBI门控心肌灌注显像在2型糖尿病无症状心肌缺血患者中的价值[J].国际放射医学核医学杂志,2016,40(3):171.[doi:10.3760/cma.j.issn.1673-4114.2016.03.002]
Fan Xiaolian,Shu Yi,Zeng Chunping,et al.Significance of 99Tcm-MIBI gated myocardial perfusion imaging in patients with type 2 diabetes but without myocardial ischemia symptoms[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):171.[doi:10.3760/cma.j.issn.1673-4114.2016.03.002]
[3]储小飞,赵舒怡,樊赛军.肿瘤干细胞与辐射抗性的研究进展[J].国际放射医学核医学杂志,2015,39(5):431.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 019]
chu xiaofei,zhao shuyi,fan saijun..advance progress of cancer stem cells and radioresistance[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):431.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 019]
[4]成钊汀,朱小华.99Tcm-MIBI显像在甲状旁腺功能亢进症中的应用及进展[J].国际放射医学核医学杂志,2015,39(1):37.[doi:10.3760/cma.j.issn.1673-4114.2015.01.009]
Cheng Zhaoting,Zhu Xiaohua.Application and progress of 99Tcm-MIBI scintieraphy in parathyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):37.[doi:10.3760/cma.j.issn.1673-4114.2015.01.009]
[5]胡鸿,唐刚华,聂大红.乳腺癌分子显像研究进展[J].国际放射医学核医学杂志,2015,39(1):91.[doi:10.3760/cma.j.issn.1673-4114.2015.01.019]
Hu Hong,Tang Ganghua,Nie Dahong.Progress on molecular imaging of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):91.[doi:10.3760/cma.j.issn.1673-4114.2015.01.019]
[6]黄娟,颜剑豪,梁联保,等.注射钆剂后弥散加权成像对乳腺肿瘤诊断的影响[J].国际放射医学核医学杂志,2015,39(4):287.[doi:10.3760/cma.j.issn.1673-4114.2015.04.003]
Huang Juan,Yan Jianhao,Liang Lianbao,et al.Evaluation of the diffusion-weighted imaging after contrast for the characterization of breast tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):287.[doi:10.3760/cma.j.issn.1673-4114.2015.04.003]
[7]李雯,冯彦林.18F-FDG PET/CT评估三阴性乳腺癌新辅助化疗疗效的研究进展[J].国际放射医学核医学杂志,2014,38(3):197.[doi:10.3760/cma.j.issn.1673-4114.2014.03.013]
Li Wen,Feng Yanlin.Advances of assessment with 18F-FDG PET/CT in triple-negative breast cancer during neoadjuvant chemotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(6):197.[doi:10.3760/cma.j.issn.1673-4114.2014.03.013]
[8]殷丽娜,张旭霞,张俊香,等.Wnt/β-catenin信号通路——乳腺癌的潜在治疗靶点[J].国际放射医学核医学杂志,2014,38(4):252.[doi:10.3760/cma.j.issn.1673-4114.2014.04.011]
Yin Lina,Zhang Xuxia,Zhang Junxiang,et al.The Wnt/β-catenin signaling pathway-a potential therapeutic target of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(6):252.[doi:10.3760/cma.j.issn.1673-4114.2014.04.011]
[9]刘超,邓智勇,刘鹏杰,等.89SrCL2与唑来膦酸联合治疗乳腺癌转移性骨肿瘤的疗效分析[J].国际放射医学核医学杂志,2014,38(5):300.[doi:10.3760/cma.j.issn.1673-4114.2014.05.006]
Liu Chao,Deng Zhi-yong,Liu Peng-jie,et al.Analysis on the curative effect of combination therapy with zoledronic acid and 89SrCL2 on bone tumor with breast cancer metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(6):300.[doi:10.3760/cma.j.issn.1673-4114.2014.05.006]
[10]胡梦裳,章斌.PET/CT显像在乳腺癌疗效评价及预后中的作用[J].国际放射医学核医学杂志,2014,38(5):332.[doi:10.3760/cma.j.issn.1673-4114.2014.05.013]
Hu Meng-shang,Zhang Bin.The role of PET/CT imaging in the evaluation of the efficacy and prognosis of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(6):332.[doi:10.3760/cma.j.issn.1673-4114.2014.05.013]
[11]杨雷,袁卫红,王家平,等.99Tcm-MIBI显像与钼靶X线对乳腺癌诊断的比较研究[J].国际放射医学核医学杂志,2016,40(2):111.[doi:10.3760/cma.j.issn.1673-4114.2016.02.005]
Yang Lei,Yuan Weihong,Wang Jiaping,et al.Diagnostic value of technetium 99Tcm sestamibi and X-ray mammography in breast cancer: a comparison study[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):111.[doi:10.3760/cma.j.issn.1673-4114.2016.02.005]
[12]夏晓天,张永学.影像学检查在乳腺癌的诊断及疗效评估中的应用价值[J].国际放射医学核医学杂志,2010,34(4):242.[doi:10.3760/cma.j.issn.1673-4114.2010.04.014]
XIA Xiao-tian,ZHANG Yong-xue.The value of imaging examinations in diagnosis and curative effect evaluation of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(6):242.[doi:10.3760/cma.j.issn.1673-4114.2010.04.014]